MMP9 and myeloid sarcoma: A study by Sanoobar et al. [90] reported the ability of CoQ10 supplementation to reduce the circulatory levels of the inflammatory markers (TNF, IL-6, and metallopeptidase 9; MMP-9) in MS patients.